Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-04-15

Clinical Trial Update: SJ733 Induced Blood Stage Malaria Challenge Study [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for SJ733 inducing blood-stage malaria, completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SJ733 (SJ733)

Snippet

Sponsor: Medicines for Malaria Venture | Conditions: Plasmodium Falciparum Malaria | Phase 1 | Status: COMPLETED | Results posted: 2020-04-15